Search

everythinglearnresearchcommunity

for

Search:↓

Early-stage male pattern baldness shows two types of hair loss: one on the top of the head linked to hormonal changes, and another at the back of the head. The top hair loss responds well to specific treatment, while the back hair loss does not.

Hair loss treatment using stem cells from baby teeth was effective for 75% of men tested, with mild side effects. A scoring system may predict how well this treatment works.

Exosomes from certain stem cells can promote hair growth and counteract hair loss caused by hormones by regulating growth factors and other cellular signals.

Platelet-rich plasma treatment is generally safe and effective for hair loss, acne scars, skin discoloration, and facial rejuvenation, but deeper injections are better and multiple treatments can increase risk of side effects.

Ganoderma lucidum extract promotes hair growth in bald rats, with higher doses producing better results, similar to the effects of Minoxidil 2%.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Minoxidil may cause vision problems.

TH07 is a topical combination of finasteride, latanoprost, and minoxidil, and shows promise.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Minoxidil and finasteride are common but limited treatments for hair loss, with new therapies showing promise.

Oral Minoxidil effectively treats male pattern baldness.

There's a significant link between severe hair loss and metabolic syndrome in Saudi Arabia, suggesting early health checks could prevent future issues.

Coenzyme Q10 in nanocarriers improves treatment for hair loss.

Botulinum toxin may be helpful for treating male pattern baldness.

Combining SVF cells with PRP may boost hair growth in androgenic alopecia.

The treatment showed promising hair growth results but needs more research.

Sansevieria trifasciata P. extracts, especially the ethyl acetate fraction, effectively promote hair growth in male rabbits with hair loss.

Low-dose oral minoxidil effectively treats male pattern baldness.

Hair loss in young men in Central India is linked to severe heart disease.

Platelet-rich plasma injections effectively treat hair loss in both men and women, increasing hair density with high patient satisfaction and no significant side effects.

The 1550 nm fractional Er:Glass laser improved hair regrowth in patients with androgenic alopecia, but didn't significantly change collagen type I, skin fibroblasts, or macrophages. More research is needed for optimal results.

Dermoscopy shows that varying hair shaft thickness and single hair follicles are main signs of male pattern baldness, especially in the fronto-temporal region.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

The 1540nm fractional erbium-glass laser helps treat hair loss caused by hormones.

Polymeric nanoparticles with dutasteride may effectively treat hair loss by targeting hair follicles.

Flibanserin's effectiveness for low sexual desire in premenopausal women may vary based on hormone levels, with normal hormone levels showing better responses.

Sex hormones may be linked to inflammation in Hidradenitis Suppurativa.

The best mix for a hair loss treatment cream is 10% Sophora japonica tincture and 5% Serenoa repens extract.

The levels of zinc, vitamin D, ferritin, and selenium are different in people with androgenic alopecia compared to a control group.

Male pattern baldness may be an early sign of noncancerous prostate enlargement.